Related Experiment Video
Updated: Jun 3, 2026
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
Translating basic research in cancer patient care
Marcello Maugeri-Saccà1, Ruggero De Maria
1Dipartimento di Ematologia, Oncologia e Medicina Molecolare, Istituto Superiore di Sanità, Rome, Italy.
Abstract:
With the advent of molecular targeted therapies and the development of high-throughput biotechnologies, it has become evident that progress in cancer research is largely due to the creation of multidisciplinary teams able to plan clinical trials supported by appropriate molecular hypotheses. These efforts have culminated in the identification and validation of biomarkers predictive of response, as well as in the generation of more accurate prognostic tools. The identification of cancer stem cells has provided further insights into mechanisms of cancer, and many studies have tried to translate this biological notion into prognostic and predictive information. In this regard, new agents targeting key stemness-related pathways have entered the clinical development, and preliminary data suggested an encouraging antitumor activity.
Insights
Multidisciplinary teams and molecular hypotheses drive cancer research progress. Biomarker discovery and cancer stem cell research are yielding new targeted therapies with promising antitumor activity.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Cancer research progress relies on multidisciplinary teams and molecular hypotheses.
- High-throughput biotechnologies enable biomarker identification and prognostic tool development.
- Cancer stem cell research offers insights into cancer mechanisms.
Purpose of the Study:
- To highlight the role of multidisciplinary teams in advancing cancer research.
- To discuss the significance of biomarkers and cancer stem cells in clinical applications.
- To review novel therapeutic strategies targeting stemness pathways.
Main Methods:
- Review of current literature on molecular targeted therapies.
- Analysis of high-throughput biotechnologies in biomarker discovery.
- Examination of studies on cancer stem cells and stemness pathways.
Main Results:
- Multidisciplinary efforts have led to validated predictive biomarkers and improved prognostic tools.
- Cancer stem cell identification provides new avenues for prognostic and predictive information.
- Emerging agents targeting stemness pathways show encouraging preliminary antitumor activity.
Conclusions:
- Integrated approaches combining molecular insights and clinical trials are crucial for cancer research advancement.
- Biomarkers and cancer stem cell-targeted therapies represent a promising frontier in oncology.
- Further clinical development of stemness-targeting agents is warranted based on initial findings.
Related Concept Videos
01:21Cancer Survival Analysis
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:18Cancer
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...